![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Hvivo Plc | LSE:HVO | London | Ordinary Share | GB00B9275X97 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.50 | 1.83% | 27.75 | 27.50 | 28.00 | 27.75 | 27.25 | 27.25 | 696,922 | 14:49:29 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 56.04M | 16.12M | 0.0237 | 11.65 | 185.4M |
TIDMORPH
RNS Number : 2213X
Open Orphan PLC
17 December 2019
The Form 8 announcement released on 17/12/19 at 10:19 under RNS No 0632X has been amended.
The full amended text is shown below.
Open Orphan plc
("Open Orphan" or the "Company")
Disclosure under rule 8.1 and 8.2 of the Takeover Code
In accordance with Takeover code rule 8.1, the Company makes the following announcement:
FORM 8 (OPD)
PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER
Rules 8.1 and 8.2 of the Takeover Code (the "Code")
1. KEY INFORMATION (a) Full name of discloser: Open Orphan plc (b) Owner or controller of interests and short positions disclosed, if different from 1(a): N/A The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. ----------------- (c) Name of offeror/offeree in relation to whose relevant securities this form relates: Open Orphan plc Use a separate form for each offeror/offeree ----------------- (d) Is the discloser the offeror or the offeree? OFFEROR ----------------- (e) Date position held: 13 December 2019 The latest practicable date prior to the disclosure ----------------- (f) In addition to the company in 1(c) above, is the discloser making disclosures in respect NO of any other party to the offer? If it is a cash offer or possible cash offer, state "N/A" ----------------- 2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE
If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.
(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates
Class of relevant security: Ordinary Shares of 0.1p each Interests Short positions ------------------ ------------------ Number % Number % ------------- --- ------------- --- (1) Relevant securities owned and/or controlled: None None ------------- --- ------------- --- (2) Cash-settled derivatives: None None ------------- --- ------------- --- (3) Stock-settled derivatives (including options) and agreements to None None purchase/sell: ------------- --- ------------- --- None None TOTAL: ------------- --- ------------- ---
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
(b) Rights to subscribe for new securities Class of relevant security in relation to which subscription right exists: None Details, including nature of the rights concerned and relevant percentages: None ----- 3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure: Details of Concert Party shareholdings: % of current Current total Raglan Road Capital Limited 21,536,124 8.46% ----------- ------------- Pamela Iver 14,880,721 5.85% ----------- ------------- Horizon Medical Technologies Limited 4,630,136 1.82% ----------- ------------- Anthony Richardson 16,313,388 6.41% ----------- ------------- Brendan Buckley 7,845,860 3.08% ----------- ------------- Crow Rock Capital Limited 7,845,860 3.08% ----------- ------------- Dairine Dempsey 3,138,344 1.23% ----------- ------------- Ian O'Connell 3,138,344 1.23% ----------- ------------- Montana Capital Limited 1,376,466 0.54% ----------- ------------- Clydagh Limited 1,376,466 0.54% ----------- ------------- Pat O'Neill 1,569,172 0.62% ----------- ------------- McNolan Ventures Limited 470,974 0.19% ----------- ------------- Carol Dalton 313,983 0.12% ----------- ------------- Bridget Chisolm 313,983 0.12% ----------- ------------- Ross Crocket 313,983 0.12% ----------- ------------- Dennis Jennings 1,003,332 0.39% ----------- ------------- Tom Tierney 2,006,665 0.79% ----------- ------------- Mount Amber International Limited 5,016,291 1.97% ----------- ------------- Francoise Richardson 1,805,136 0.71% ----------- ------------- Gary Duffy 539,654 0.21% ----------- ------------- Details of concert party options/warrants: Options over Open Orphan shares Raglan Road Capital Limited 3,250,000 ------------- Cathal Friel CMF Pension Fund 657,285 ------------- Dan Cronin 539,654 ------------- Michael Fleming 269,866 ------------- Pa Nolan 269,866 ------------- Maurice Treacy* 7,716,964 ------------- Details of Director shareholdings (excluding those in the Concert Party) Options over Open Orphan shares Michael Ryan 134,586 ------------- Details of Director options (excluding those in the Concert Party) Options over Grant date Exercise Expiry date Open Orphan price per shares share (pence) Christian Milla 770,000 14/09/2017 13 13/09/2027 ------------- ----------- --------------- ------------ Michael Ryan 200,000 14/09/2017 13 13/09/2027 ------------- ----------- --------------- ------------ *Maurice Treacy's options were granted on 28/06/2019, with an exercise price per share of 5.6 pence and expiry date of 27/06/2022
Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).
Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).
4. OTHER INFORMATION (a) Indemnity and other dealing arrangements Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none" None (b) Agreements, arrangements or understandings relating to options or derivatives Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none" None (c) Attachments
Are any Supplemental Forms attached?
Supplemental Form 8 (Open Positions) NO Supplemental Form 8 (SBL) NO --- Date of disclosure: 17 December 2019 Contact name: Cathal Friel, Chief Executive Officer -------------------------------------- Telephone number: +353 (0)1 644 0007 --------------------------------------
Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.
The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
FEEFMMMZVNFGLZM
(END) Dow Jones Newswires
December 17, 2019 11:36 ET (16:36 GMT)
1 Year Hvivo Chart |
1 Month Hvivo Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions